Ally Bridge Group (NY) LLC Quant / Systematic

Location: New York, NY

CIK: 0001822947 · Show all filings

Period: Q2 2025 (← Previous) (Next →)

Filing Date: Aug 14, 2025

Total Value: $120M (100.0% shares, 0.0% debt)

Holdings (24)

VERONA PHARMA PLC 12.6%
Value $15.2M Shares 160,701 Est. Cost $67.68 Unrealized
SLNO SOLENO THERAPEUTICS INC 12.5%
Value $14.98M Shares 178,819 Est. Cost $58.76 Unrealized +27.4%
LENZ LENZ THERAPEUTICS INC 8.4%
Value $10.06M Shares 343,322 Est. Cost $27.20 Unrealized 0.0%
MERUS N V 6.1%
Value $7.375M Shares 140,208 Est. Cost $37.43 Unrealized
ULTRAGENYX PHARMACEUTICAL IN 4.8%
Value $5.818M Shares 1,600 Est. Cost $3636.00 Unrealized
ELVN ENLIVEN THERAPEUTICS INC 4.7%
Value $5.645M Shares 281,394 Est. Cost $21.32 Unrealized -11.2%
ORIC ORIC PHARMACEUTICALS INC 4.1%
Value $4.929M Shares 485,629 Est. Cost $6.71 Unrealized 0.0%
REPL REPLIMUNE GROUP INC 4.1%
Value $4.91M Shares 528,491 Est. Cost $8.73 Unrealized 0.0%
TARS TARSUS PHARMACEUTICALS INC 4.1%
Value $4.909M Shares 121,182 Est. Cost $28.11 Unrealized +60.1%
INSM INSMED INC 4.0%
Value $4.802M Shares 47,710 Est. Cost $34.62 Unrealized +120.9%
MIND MEDICINE MINDMED INC 3.9%
Value $4.713M Shares 726,172 Est. Cost $7.76 Unrealized
GERN GERON CORP 3.8%
Value $4.585M Shares 3,251,475 Est. Cost $2.12 Unrealized -33.1%
CMPS COMPASS PATHWAYS PLC 3.5%
Value $4.158M Shares 1,485,000 Est. Cost $2.80 Unrealized
CNTA CENTESSA PHARMACEUTICALS PLC 3.2%
Value $3.863M Shares 293,986 Est. Cost $15.50 Unrealized
RNAM AVIDITY BIOSCIENCES INC 3.1%
Value $3.77M Shares 132,744 Est. Cost $29.81 Unrealized 0.0%
SLDB SOLID BIOSCIENCES INC 2.9%
Value $3.526M Shares 724,000 Est. Cost $3.54 Unrealized 0.0%
LXEO LEXEO THERAPEUTICS INC 2.9%
Value $3.487M Shares 867,302 Est. Cost $3.29 Unrealized 0.0%
PRAX PRAXIS PRECISION MEDICINES I 2.8%
Value $3.401M Shares 80,880 Est. Cost $48.59 Unrealized -21.6%
TECX TECTONIC THERAPEUTIC INC 2.7%
Value $3.252M Shares 163,683 Est. Cost $30.22 Unrealized -32.9%
KRRO KORRO BIO INC 1.6%
Value $1.926M Shares 154,223 Est. Cost $28.72 Unrealized -49.9%
WHWK WHITEHAWK THERAPEUTICS INC 1.3%
Value $1.53M Shares 817,939 Est. Cost $2.27 Unrealized -23.2%
ATYR ATYR PHARMA INC 1.2%
Value $1.459M Shares 287,720 Est. Cost $3.09 Unrealized +27.4%
MNPR MONOPAR THERAPEUTICS INC 1.0%
Value $1.236M Shares 34,537 Est. Cost $36.32 Unrealized 0.0%
PROMIS NEUROSCIENCES INC 0.5%
Value $646K Shares 1,334,428 Est. Cost $1.46 Unrealized